Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Bruce W. Kirkham
Based on 20 articles published since 2010
(Why 20 articles?)
||||
Expertise Level
The expertise of Bruce W. Kirkham ranks in the
  • Top 0.46%
  • ... of 42,368 published authors worldwide on Psoriasis
  • ... from 2010 through 2020
  • ... based on contributions to 20 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Kirkham, Bruce   ·   Kirkham, Bruce W   ·   Kirkham, B W   ·   Kirkham, B
Work Locations
Details
Most likely:    Guy's and St Thomas' NHS Trust      
2018
  • University of Oxford, Oxford, UK. · Swedish Medical Centre and University of Washington, Seattle. · Sorbonne Universités, UPMC Université Paris 06, GRC-UPMC 08, and Pitié Salpêtrière Hospital, AP-HP, Paris, France. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · RTI Health Solutions, Research Triangle Park, North Carolina. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Pubmed 29409133
  • Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow, G12 8TA, UK. · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Friedrich-Alexander University of Erlangen-Nuremberg and Universitatsklinikum Erlangen, Erlangen, Germany. · Guy's & St Thomas' NHS Foundation Trust, London, UK. · Stanford University School of Medicine, Palo Alto, CA, USA. · RTI Health Solutions, Durham, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 29880010
  • BresMed Health Solutions, Sheffield, UK. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharmaceuticals UK Limited, Camberley, UK. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · King's College London, London, UK. · Pubmed 29797187
2017
  • Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK. · Division of Rheumatology Clinical Research, Swedish Medical Centre and University of Washington, Seattle, WA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Faculty of Medicine, Memorial University, St. John's, NL, Canada. · Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Pubmed 28968735
  • Department of Medicine, University of Queensland, Rheumatology Research Unit, Sunshine Coast, QLD, Australia. Electronic address: · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Immuno-Rheumatology Center, St Luke's International University, St Luke's International Hospital, Tokyo, Japan. · Department of Medicine, Memorial University, St Clare's Mercy Hospital, St John's, NL, Canada. · Departement of Rheumatology, Lapeyronie Hospital, Montpellier Université, Montpelier, France. · Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Medicine, Stanford University, Palo Alto, CA, USA. · Pubmed 28551073
2016
  • Clinical Training Fellow. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Professor in Immunobiology and head of the Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Consultant Rheumatologist in the Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT. · Pubmed 27388392
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of California San Diego School of Medicine, San Diego, CA, USA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Memorial University, Newfoundland, NL, Canada. · Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands. · Amsterdam Rheumatology and Immunology Center, Amsterdam, and Atrium Medical Center, Heerlen, Netherlands. · NIHR Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, UK. · Department of Dermatology, Tufts Medical Center, Boston, MA, USA. · Novartis Pharma, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Healthcare, Hyderabad, India. · Pubmed 26135703
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
2014
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23819583
2019
  • From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · Pubmed 31154403
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, , London, UK. · Pubmed 23994863
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
Probable:    University of London      
2018
  • BresMed Health Solutions, Sheffield, UK. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharmaceuticals UK Limited, Camberley, UK. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · King's College London, London, UK. · Pubmed 29797187
2019
  • From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · Pubmed 31154403
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2015
  • Centre for Molecular and Cellular Biology of Inflammation (CMCBI), Division of Immunology, Infection and Inflammatory Disease, King's College London, London, SE1 1UL, UK, · Pubmed 26209291
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
Probable:    University of Glasgow      
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 20 total) written by Bruce W. Kirkham about Psoriasis:

  • Best-practice Indicators in Psoriatic Disease Care. 2019
  • Minimal Disease Activity Among Active Psoriatic Arthritis Patients Treated With Secukinumab: 2-Year Results From a Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase III Study. 2018
  • Secukinumab provides rapid and sustained pain relief in psoriatic arthritis over 2 years: results from the FUTURE 2 study. 2018
  • Cost Effectiveness of Secukinumab for the Treatment of Active Psoriatic Arthritis in the UK. 2018
  • Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study. 2017
  • Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial. 2017
  • Basic and Translational Science: A Report from the GRAPPA 2016 Annual Meeting. 2017
  • Psoriatic arthritis. 2016
  • Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis. 2015
  • Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis. 2015
Show List of Full Article Records
Google Searches

Learn more about Bruce W. Kirkham using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Guy's and St Thomas' NHS Trust
University of London
University of Glasgow
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Guy's and St Thomas' NHS Trust
2018
  • University of Oxford, Oxford, UK. · Swedish Medical Centre and University of Washington, Seattle. · Sorbonne Universités, UPMC Université Paris 06, GRC-UPMC 08, and Pitié Salpêtrière Hospital, AP-HP, Paris, France. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · RTI Health Solutions, Research Triangle Park, North Carolina. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, New Jersey. · Pubmed 29409133
  • Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, 120 University Place, Glasgow, G12 8TA, UK. · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Friedrich-Alexander University of Erlangen-Nuremberg and Universitatsklinikum Erlangen, Erlangen, Germany. · Guy's & St Thomas' NHS Foundation Trust, London, UK. · Stanford University School of Medicine, Palo Alto, CA, USA. · RTI Health Solutions, Durham, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Pubmed 29880010
  • BresMed Health Solutions, Sheffield, UK. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharmaceuticals UK Limited, Camberley, UK. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · King's College London, London, UK. · Pubmed 29797187
2017
  • Institute of Infection Immunity and Inflammation, University of Glasgow, Glasgow, UK. · Division of Rheumatology Clinical Research, Swedish Medical Centre and University of Washington, Seattle, WA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Faculty of Medicine, Memorial University, St. John's, NL, Canada. · Department of Dermatology, New York Medical College, Valhalla, NY, USA. · Rheumatology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Pharma, Basel, Switzerland. · Pubmed 28968735
  • Department of Medicine, University of Queensland, Rheumatology Research Unit, Sunshine Coast, QLD, Australia. Electronic address: · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Immuno-Rheumatology Center, St Luke's International University, St Luke's International Hospital, Tokyo, Japan. · Department of Medicine, Memorial University, St Clare's Mercy Hospital, St John's, NL, Canada. · Departement of Rheumatology, Lapeyronie Hospital, Montpellier Université, Montpelier, France. · Department of Rheumatology and Clinical Immunology, Charite University Medicine Berlin, Campus Mitte, Berlin, Germany. · Eli Lilly and Company, Indianapolis, IN, USA. · Department of Medicine, Stanford University, Palo Alto, CA, USA. · Pubmed 28551073
2016
  • Clinical Training Fellow. Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Professor in Immunobiology and head of the Centre for Molecular and Cellular Biology of Inflammation, Division of Immunology, Infection and Inflammatory Disease, King's College London, London. · Consultant Rheumatologist in the Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London SE1 9RT. · Pubmed 27388392
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
  • Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, UK. Electronic address: · Swedish Medical Center and University of Washington, Seattle, WA, USA. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of California San Diego School of Medicine, San Diego, CA, USA. · Allergy/Immunology and Rheumatology Division, University of Rochester, Rochester, NY, USA. · Memorial University, Newfoundland, NL, Canada. · Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands. · Amsterdam Rheumatology and Immunology Center, Amsterdam, and Atrium Medical Center, Heerlen, Netherlands. · NIHR Leeds Musculoskeletal Biomedical Research Unit and University of Leeds, Leeds, UK. · Department of Dermatology, Tufts Medical Center, Boston, MA, USA. · Novartis Pharma, Basel, Switzerland. · Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA. · Novartis Healthcare, Hyderabad, India. · Pubmed 26135703
  • Guy's and St Thomas' NHS Foundation Trust, London, UK. · Katholieke Universiteit Leuven, Leuven, Belgium. · Quintiles, Collegeville, PA, USA. · Pfizer Inc, Collegeville, PA, USA. · Pfizer Europe, Rome, Italy. · Pubmed 25535650
2014
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23819583
2019
  • From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · Pubmed 31154403
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
  • Department of Rheumatology, Guy's & St Thomas' NHS Foundation Trust, , London, UK. · Pubmed 23994863
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
University of London
2018
  • BresMed Health Solutions, Sheffield, UK. · RTI Health Solutions, Research Triangle Park, NC, USA. · Novartis Pharma AG, Basel, Switzerland. · Novartis Healthcare Private Limited, Hyderabad, India. · Novartis Pharmaceuticals UK Limited, Camberley, UK. · Guy's and St Thomas' NHS Foundation Trust, London, UK. · King's College London, London, UK. · Pubmed 29797187
2019
  • From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · From the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds; Bradford Hospitals National Health Service (NHS) Foundation Trust, Bradford; Global Strategy Group, Healthcare and Life Sciences, KPMG LLP, London; Guy's and St. Thomas' NHS Foundation Trust, Kings College London, London; University of Oxford, Oxford, UK; University of Toronto, Toronto, Ontario; Toronto Western Hospital, Toronto, Ontario, Canada; Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, Buenos Aires; University Institute Hospital Italiano de Buenos Aires, Buenos Aires; Argentina; Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain; Division of Dermatology and Venereology, Geneva University Hospitals, Geneva; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland; Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck, Luebeck, Germany. · P.S. Helliwell, DM, PhD, FRCP, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and Bradford Hospitals NHS Foundation Trust; G. Favier, PhD, Global Strategy Group, Healthcare and Life Sciences, KPMG LLP; D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; and Senior Scientist, Krembil Research Institute, Toronto Western Hospital, and co-Chair, GRAPPA Publication Committee; E.R. Soriano, MD, MSc, Rheumatology Unit, Internal Medicine Services, Hospital Italiano de Buenos Aires, and University Institute Hospital Italiano de Buenos Aires; B.W. Kirkham, MD, FRCP, FRACP, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, Professor of Translational Rheumatology, Kings College London; L.C. Coates, MB ChB, MRCP, PhD, University of Oxford; L. Puig, MD, PhD, Hospital de la Santa Creu I Sant Pau, Universitat Autònoma de Barcelona; W.H. Boehncke, MD, Professor, Chair, Division of Dermatology and Venereology, Geneva University Hospitals, and Department of Pathology and Immunology, University of Geneva; D. Thaçi, MD, Research Institute and Comprehensive Center for Inflammation Medicine, University of Luebeck. · Pubmed 31154403
2017
  • From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · From Clinical Investigation, The Rockefeller University, New York; Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center, Rochester, New York, USA; Guy's and St. Thomas' UK National Health Service (NHS) Foundation Trust; King's College London, London, UK. · J.G. Krueger, MD, PhD, D. Martin Carter Professor in Clinical Investigation, The Rockefeller University; B. Kirkham, MD, Consultant Rheumatologist, Guy's and St. Thomas' NHS Foundation Trust, and Professor of Translational Rheumatology, King's College London; C.T. Ritchlin, MD, MPH, Professor of Medicine, Division of Allergy, Immunology, and Rheumatology, University of Rochester Medical Center. · Pubmed 28461524
2015
  • Centre for Molecular and Cellular Biology of Inflammation (CMCBI), Division of Immunology, Infection and Inflammatory Disease, King's College London, London, SE1 1UL, UK, · Pubmed 26209291
2014
  • King's College London and Guy's and St. Thomas' Hospitals Foundation NHS Trust, London, UK. · Pubmed 24470327
2013
  • St John's Institute of Dermatology, Division of Genetics and Molecular Medicine, King's College London and Guy's & St Thomas' NHS Foundation Trust, London, UK. · Pubmed 23278714
University of Glasgow
2015
  • From the Swedish Medical Center and the University of Washington - both in Seattle (P.J.M.) · University of Glasgow, Glasgow (I.B.M.), and Guy's and St. Thomas' NHS Foundation Trust, London (B.K.) - both in the United Kingdom · University of California, San Diego, School of Medicine, San Diego (A.K.) · Memorial University, St. John's, NL, Canada (P.R.) · Leiden University Medical Center, Leiden (D.H.), and University of Amsterdam and Atrium Medical Center, Amsterdam (R.L.) - all in the Netherlands · University of Queensland, Brisbane, Australia (P.N.) · Novartis Pharmaceuticals, East Hanover, NJ (L.P., J.Y.) · and Novartis Pharma, Basel, Switzerland (H.B.R., S.M.). · Pubmed 26422723
14 Other Locations Show
Yearly article counts 01331452001
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.